Applied Aerospace & Defense, Inc. (AADX) is a Huntsville, Alabama-based manufacturer of integrated aerospace and defense subsystems that completed its initial public offering in June 2026. As a newly public, loss-making company, its analyst coverage is still maturing, and price targets have moved sharply lower in recent months as the stock has fallen from its post-IPO highs.
Seven verifiable, current price targets were reviewed. The most recent include Morgan Stanley (Kristine Liwag) at $16 with an Equal-Weight rating, RBC Capital (Ken Herbert) at $18 with an Outperform rating, Jefferies at $20 with a Buy rating, Bank of America (Ronald Epstein) at $23 with a Buy rating, and Stifel at $24 with a Buy rating. Guggenheim (Michael Ciarmoli) and Baird (Peter Arment) both carry higher targets of $30. The low-to-high range is therefore $16 to $30, and the arithmetic mean of these seven targets is approximately $23.
The dispersion is notable. Morgan Stanley's cautious $16 reflects integration risks and execution concerns, while the $30 targets from Guggenheim and Baird rest on the company's competitive position, robust backlog, and a valuation discount relative to peers. There is no single "analyst consensus" figure that all sources report identically, and the $23 average should be read as a midpoint across genuinely divergent views rather than a precise forecast.
Shares traded near $9.15 on November 11, 2026, after a steep single-day decline tied to a reduced outlook. From that level, reaching $23 implies a required move of about 150%, which is very large by any standard. The stock's 52-week range of roughly $8.40 to $24.24 shows it has already traded near the target zone before reversing lower.
The company reported third-quarter revenue growth of about 49%, with quarterly revenue of roughly $182 million and EPS (earnings per share) of $0.18, both ahead of consensus estimates. However, management also lowered full-year 2026 revenue guidance to $660–$670 million — below the consensus of about $682 million — and set adjusted EBITDA (earnings before interest, taxes, depreciation, and amortization) guidance of $137–$142 million, citing supplier and approval delays and program ramp costs. That guidance reset is central to the stock's decline.
Applied Aerospace & Defense benefits from structurally strong demand in space launch and defense, including work with high-profile commercial space and defense customers. Roughly 87% of revenue stems from sole- or single-source awards with blue-chip prime contractors, supporting revenue visibility. Record bookings and backlog provide a foundation for future sales, and management has indicated it expects margin recovery toward the high-20% range in the second half of 2027.
If execution improves, supplier constraints ease, and the company converts backlog into revenue while expanding margins, the current valuation — roughly 2.8 times trailing sales with no meaningful P/E (price-to-earnings) multiple because the company is unprofitable — could re-rate higher. Positive analyst revisions would also reinforce the path toward the average price target.
The clearest obstacle is the downward revision to fiscal 2026 guidance, which signals that near-term execution and ramp costs are weighing on results. The company remains loss-making on a trailing basis, carries meaningful debt relative to equity, and is still working through integration following its IPO. Customer concentration in a handful of prime contractors adds concentration risk.
Further guidance cuts, slower backlog conversion, continued margin pressure, or broader sector rotation away from high-growth aerospace names could keep the stock well below the $23 average analyst target. Technical resistance is also relevant, given that the shares recently set a new 52-week low.
The stock's 52-week low near $8.40 acts as a key support level, while the recent breakdown below prior price levels leaves the 50-day moving average near $11.81 as an overhead area to reclaim. The $23 target sits roughly in the upper portion of the stock's historical trading range, and the $24.24 52-week high marks a meaningful resistance level just above it. Short interest of roughly 3.9% of shares outstanding is a modest consideration but not the dominant driver of the price action.
Analyst price targets generally reflect a forward research horizon, most commonly around 12 months, though individual horizons can differ. Investors should watch quarterly revenue and bookings trends, margin progression, and any further changes to full-year guidance, as well as analyst target revisions and rating changes. Supplier-approval timing and the pace of program ramps are the key operational variables most likely to move the stock toward or away from the $23 level.
Tickeron's AI Daily Buy/Sell Signals use artificial intelligence to continuously monitor thousands of stocks and ETFs, generating Buy, Sell, or Hold signals based on changing market conditions, technical behavior, and AI-driven analysis. Traders can use these signals to discover new opportunities, monitor existing positions, and identify shifting trends more efficiently than manual screening alone. For investors tracking names like AADX, integrating AI-generated signals alongside fundamental research can provide an additional lens on market momentum.
The question of whether AADX can reach $23 hinges on a very large, roughly 150% move from current levels. The $23 central target — the average of seven analyst targets spanning $16 to $30 — captures genuine disagreement about the company's trajectory. Bulls point to record bookings, sole-source relationships, and strong end-market demand; bears point to a reduced 2026 outlook, ongoing losses, and execution risk. The wide range itself signals above-average uncertainty. Investors should monitor guidance revisions, backlog conversion, and margin trends rather than treating the average price target as a reliable destination.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.